Aldawaa Medical Services Co. (4163) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Consumer Staples Distribution & Retail. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2024, Aldawaa Medical Services Co. reported revenue of SAR 6.45B, net profit of SAR 370M, and earnings per share of SAR 4.35. Total assets stood at SAR 5.04B with total equity of SAR 1.46B and total liabilities of SAR 3.58B.

Operating cash flow for 2024 was SAR 683M, representing a cash conversion ratio of 1.85 relative to net profit. Free cash flow was SAR 585M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2024, SAR 1.85 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.85.

Revenue growth from 2023 to 2024: +12.4%. Net profit growth over the same period: +12.4%. 3-year revenue CAGR: 27.1%. 3-year net profit CAGR: 15.7%.

Key financial ratios for 2024: Return on Equity 25.4%, Return on Assets 7.3%, Net Margin 5.7%, Debt to Equity 2.46.

In 2023, Aldawaa Medical Services Co. reported revenue of SAR 5.74B and net profit of SAR 329M, compared to SAR 6.45B and SAR 370M respectively in 2024.